216 related articles for article (PubMed ID: 34655202)
1. Artemether Attenuates Aβ25-35-Induced Cognitive Impairments by Downregulating Aβ, BACE1, mTOR and Tau Proteins.
Li HJ; Wang TZ; Hou C; Liu HY; Zhang Y; Xue ZZ; Cai QC; Chen DM; Gao CW; Yang JL; Cong L; Chen Y; Yao Q; Zhu QS; Cao C
Clin Lab; 2021 Oct; 67(10):. PubMed ID: 34655202
[TBL] [Abstract][Full Text] [Related]
2. BACE1 RNA interference improves spatial memory and attenuates Aβ burden in a streptozotocin-induced tau hyperphosphorylated rat model.
Yu CJ; Liu W; Chen HY; Wang L; Zhang ZR
Cell Biochem Funct; 2014 Oct; 32(7):590-6. PubMed ID: 25230339
[TBL] [Abstract][Full Text] [Related]
3. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
5. δ-Secretase-cleaved Tau stimulates Aβ production via upregulating STAT1-BACE1 signaling in Alzheimer's disease.
Zhang Z; Li XG; Wang ZH; Song M; Yu SP; Kang SS; Liu X; Zhang Z; Xie M; Liu GP; Wang JZ; Ye K
Mol Psychiatry; 2021 Feb; 26(2):586-603. PubMed ID: 30382187
[TBL] [Abstract][Full Text] [Related]
6. GSK-3β as a target for apigenin-induced neuroprotection against Aβ 25-35 in a rat model of Alzheimer's disease.
Alsadat AM; Nikbakht F; Hossein Nia H; Golab F; Khadem Y; Barati M; Vazifekhah S
Neuropeptides; 2021 Dec; 90():102200. PubMed ID: 34597878
[TBL] [Abstract][Full Text] [Related]
7. Aberrant proteolytic processing and therapeutic strategies in Alzheimer disease.
Tomita T
Adv Biol Regul; 2017 May; 64():33-38. PubMed ID: 28082052
[TBL] [Abstract][Full Text] [Related]
8. Gypenoside IX restores Akt/GSK-3β pathway and alleviates Alzheimer's disease-like neuropathology and cognitive deficits.
Lei L; Luo Y; Kang D; Yang F; Meng D; Wang JZ; Liu R; Wang X; Li HL
Aging (Albany NY); 2023 Dec; 15(23):14172-14191. PubMed ID: 38095632
[TBL] [Abstract][Full Text] [Related]
9. Protopanaxadiol derivative DDPU improves behavior and cognitive deficit in AD mice involving regulation of both ER stress and autophagy.
Guo X; Lv J; Lu J; Fan L; Huang X; Hu L; Wang J; Shen X
Neuropharmacology; 2018 Mar; 130():77-91. PubMed ID: 29197516
[TBL] [Abstract][Full Text] [Related]
10. Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting β/γ-Secretases Activity and Enhancing α-Secretases.
Cai Z; Wang C; He W; Chen Y
Curr Alzheimer Res; 2018; 15(11):1045-1052. PubMed ID: 29962345
[TBL] [Abstract][Full Text] [Related]
11. Amentoflavone Ameliorates Memory Deficits and Abnormal Autophagy in Aβ
Cao B; Zeng M; Zhang Q; Zhang B; Cao Y; Wu Y; Feng W; Zheng X
Neurochem Res; 2021 Apr; 46(4):921-934. PubMed ID: 33492604
[TBL] [Abstract][Full Text] [Related]
12. Rhizophora mucronata attenuates beta-amyloid induced cognitive dysfunction, oxidative stress and cholinergic deficit in Alzheimer's disease animal model.
Suganthy N; Malar DS; Devi KP
Metab Brain Dis; 2016 Aug; 31(4):937-49. PubMed ID: 27188290
[TBL] [Abstract][Full Text] [Related]
13. BACE1: the beta-secretase enzyme in Alzheimer's disease.
Vassar R
J Mol Neurosci; 2004; 23(1-2):105-14. PubMed ID: 15126696
[TBL] [Abstract][Full Text] [Related]
14. Moringa Oleifera Alleviates Homocysteine-Induced Alzheimer's Disease-Like Pathology and Cognitive Impairments.
Mahaman YAR; Huang F; Wu M; Wang Y; Wei Z; Bao J; Salissou MTM; Ke D; Wang Q; Liu R; Wang JZ; Zhang B; Chen D; Wang X
J Alzheimers Dis; 2018; 63(3):1141-1159. PubMed ID: 29710724
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms underlying large-leaf yellow tea mediated inhibition of cognitive impairment in the 5xFAD model of Alzheimer's disease.
Tang X; Kan Z; Li N; Huang J; Zhang J; Thompson HJ; Gao F; Shen Y; Zhang L; Xie Z; Wan X; Wang Y
Phytomedicine; 2023 Nov; 120():155030. PubMed ID: 37651754
[TBL] [Abstract][Full Text] [Related]
16. Reduction of the expression of the late-onset Alzheimer's disease (AD) risk-factor
Andrew RJ; De Rossi P; Nguyen P; Kowalski HR; Recupero AJ; Guerbette T; Krause SV; Rice RC; Laury-Kleintop L; Wagner SL; Thinakaran G
J Biol Chem; 2019 Mar; 294(12):4477-4487. PubMed ID: 30692199
[TBL] [Abstract][Full Text] [Related]
17. The Effect of TCM-Induced HAMP on Key Enzymes in the Hydrolysis of AD Model Cells.
Xian-Hui D; Dong-Xue M; Tian-Ci Z; Xiao-Ping H; Li-Jun X; Ya-Lei L; Hao L; Wei-Juan G
Neurochem Res; 2021 May; 46(5):1068-1080. PubMed ID: 33683629
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of BACE1 inhibitory ligand molecules against amyloid beta-induced synaptic and mitochondrial toxicities in Alzheimer's disease.
Pradeepkiran JA; Reddy AP; Yin X; Manczak M; Reddy PH
Hum Mol Genet; 2020 Jan; 29(1):49-69. PubMed ID: 31595293
[TBL] [Abstract][Full Text] [Related]
19. Pentoxifylline as Add-On Treatment to Donepezil in Copper Sulphate-Induced Alzheimer's Disease-Like Neurodegeneration in Rats.
Elseweidy MM; Mahrous M; Ali SI; Shaheen MA; Younis NN
Neurotox Res; 2023 Dec; 41(6):546-558. PubMed ID: 37821782
[TBL] [Abstract][Full Text] [Related]
20. Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD.
Tramutola A; Triplett JC; Di Domenico F; Niedowicz DM; Murphy MP; Coccia R; Perluigi M; Butterfield DA
J Neurochem; 2015 Jun; 133(5):739-49. PubMed ID: 25645581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
